Novel transcript, antisense to Thrombospondin type-1 domain-containing protein 7A

This molecule is a **natural antisense transcript (NAT)**, meaning it is an RNA expressed from the DNA strand opposite to the protein-coding gene THSD7A. NATs are widespread in eukaryotic genomes and typically participate in regulatory roles rather than encoding proteins. The main mechanisms by which NATs act include transcriptional interference, masking of splicing or regulatory elements, production of double-stranded RNA for RNA interference, and modulation of chromatin structure. These actions can influence levels, stability, and splicing of the associated sense transcript (here, THSD7A), but are generally not recognized as direct drug targets[2][4]. There is currently no evidence this particular antisense transcript is a therapeutic or diagnostic target, nor is there structured pharmacological information about drugs or biomarkers related to it. The transcript’s primary relevance is as a possible modulator of THSD7A expression, a protein implicated in diseases such as membranous nephropathy[5][7].

Other names

Antisense transcript to THSD7ANovel transcript antisense to THSD7AENSG00000230333

not targeted by drugs; if considered mechanistically, natural antisense transcripts may influence gene expression via transcriptional interference, RNA masking, chromatin remodeling, or dsRNA-dependent processes[4]